Understanding light sensitivity in a genetic blood condition
Measuring and Understanding Light Sensitivity in Erythropoietic Protoporphyria
This study is looking at how light sensitivity affects people with erythropoietic protoporphyria (EPP) and aims to find better ways to measure this sensitivity and understand why it varies from person to person, all to help improve treatments for those living with EPP.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10877745 on NIH RePORTER |
What this research studies
This research focuses on erythropoietic protoporphyria (EPP), a condition that causes painful sensitivity to light due to a genetic defect in heme biosynthesis. The study aims to develop methods to quantitatively measure light sensitivity using advanced techniques like light dosimetry and PPIX fluorometry, alongside daily symptom surveys. Additionally, it seeks to explore the genetic factors that contribute to variations in light sensitivity among patients with the same genetic background. By understanding these differences, the research hopes to pave the way for better treatment options for EPP patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with erythropoietic protoporphyria who experience varying degrees of light sensitivity.
Not a fit: Patients without a diagnosis of erythropoietic protoporphyria or those who do not experience light sensitivity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management and treatment options for patients suffering from erythropoietic protoporphyria.
How similar studies have performed: While there has been some progress in understanding EPP, this research aims to develop novel quantitative measures for light sensitivity, making it a potentially groundbreaking approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Dickey, Amy Kathryn — Massachusetts General Hospital
- Study coordinator: Dickey, Amy Kathryn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.